Latest
Missed, misunderstood, and deadly: A Cape Town family’s heartbreak with hepatitis B
When Desmond Pedro discovered a strange hardness under his ribcage, he was just 30 and preparing for a fresh start on a government skills course. Little did he know that he would soon die of liver cancer caused by undetected hepatitis B. Sue Segar spent time with his family and spoke to experts to uncover how this overlooked virus continues to claim lives — and what can be done to stop it.
The current gonorrhoea meds might stop working – when will newer ones make it to SA?
Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Catherine Tomlinson unpacks why these new antibiotics are important and what needs to happen before they can be used in South Africa.
Electronic death registration is a win-win for SA – let’s make it happen
Several studies have flagged problems with South Africa’s death registration processes. A critical first step to addressing it is to replace our paper-based process with an electronic one, argue Dr Pam Groenewald and Professor Debbie Bradshaw, both of the SAMRC’s Burden of Disease Research Unit.
Why most people in South Africa can’t get the shingles vaccine
The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used in some other countries, but has not yet been registered in South Africa, though it can be obtained by those with money who are willing to jump through some hoops. Catherine Tomlinson reports.
Are children living with HIV being left behind? What the stats tell us
Massive gains have been made in reducing new HIV infections and deaths in children. Yet, many of the statistics for children still look worse than those for adults. Elri Voigt asked experts why this is the case and what factors prevent children living with HIV from starting and staying on the treatment that can keep them healthy.
High hopes for major TB vaccine study recently launched in Paarl
The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.
Massive $200 million TB research programme derailed by US funding cuts
Just over a month after US President Donald Trump implemented a 90-day freeze of all foreign assistance, the future looks very uncertain for tuberculosis research. Among others, a large TB research programme that was worth up to $200 million was axed last week. Elri Voigt reports.
OPEN LETTER | Minister of Health Aaron Motsoaledi, please explain the HIV numbers
Minister of Health Dr Aaron Motsoaledi’s recent claim that over half a million people have been newly started on HIV treatment in less than six months has raised eyebrows in health circles. In this open letter, Anna Grimsrud and Sibongile Tshabalala-Madhlala, associated with CHANGE – South Africa, ask the Minister to explain numbers that, on the face of it, seem contradictory.
Why some babies in South Africa are still getting HIV
Over the last two decades, South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the right puzzle pieces for prevention but failing to integrate them optimally. Elna Schütz reports.
US pulls funding for South African medical research
US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
Growing the beta variant – young scientist remembers the day they danced in the lab
During South Africa’s COVID-19 hard lockdown, rising star scientist Dr Sandile Cele spent his Christmas holidays in a laboratory. Soon the 35-year-old became the first to successfully grow the beta variant of SARS-CoV-2 in the lab. Biénne Huisman spoke to Cele about how he did this, the string of accolades he received since, and his leap from a modest upbringing to the global scientific stage.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent bibendum nulla eget lobortis finibus. Praesent a euismod nulla, vel ullamcorper lacus. Aenean auctor, nulla eu ultricies mattis, urna nisl ullamcorper purus, eu suscipit leo libero et elit. Quisque iaculis nisl a risus elementum, ac aliquam sem maximus.

-
Episode 1: Sexual and reproductive health rights
Aug 23, 2018 • 23:42
In this first episode of the Spotlight podcast host Nomatter Ndebele speaks to Dr Daphney Conco of Wits about what SRHR is and why it matters. We also hear from Vuyokazi Gonyela of TAC about their SRHR work in provinces. Finally, Nomatter chats to Spotlight guest editor Thuthu Mbatha about…
-
Episode 2: Life Esidimeni revisited
Aug 28, 2018 • 1:00:42
In episode 2 we catch up with the processes around the Life Esidimeni tragedy. Christine Nxumalo discusses what further action the families are hoping for. Tendai Mafuma provides fascinating insights into the prospects for criminal liability. Mark Heywood gives his views on the politics surrounding the case and what that…
-
Episode 3: Sasha Stevenson on what NHI and HMI means for healthcare reform in South Africa
Oct 5, 2018 • 00:18:53
At a recent civil society meeting jointly hosted by SECTION27 and Spotlight, Sasha Stevenson, head of health at SECTION27, presented on the implications of NHI and HMI for access to healthcare in South Africa. We now make her informative and thought-provoking presentation available as a podcast. (We apologise for the…
-
Episode 4: Marijuana, health and the law in South Africa
Dec 7, 2018 • 18:41
Host Nomatter Ndebele chats to Dr Michael Herbst of the Cancer Association of South Africa about the landmark Constitutional Court judgement on the possession and use of marijuana and the judgement’s implications for the health of people in South Africa.
-
Episode 5: Dr Fareed Abdullah on South Africa’s AIDS response
Dec 14, 2018 • 22:26
Dr Fareed Abdullah of the SA MRC, previously CEO of SANAC, recently addressed the TAC’s 20-year celebrations. Listen what he had to say about the history of South Africa’s AIDS response and where we are now.
-
Episode 6: Justice Edwin Cameron addresses the TAC 20-year celebrations
Dec 14, 2018 • 13:14
Justice Edwin Cameron of South Africa’s Constitutional Court recently addressed attendees at the TAC’s 20-year celebrations. We bring you a recording of what he had to say to TAC members, supporters and allies.
-
Episode 7: Lotti Rutter on PEPFAR funding and why we need a People’s COP
Jul 25, 2019 • 24:10
Nomatter Ndebele chats to Lotti Rutter of HealthGAP about what the People’s COP is and why it matters.
-
Episode 8: How South Africa is performing against key NSP indicators
Jul 25, 2019 • 19:30
Host Nomatter Ndebele chats to Spotlight editor Marcus Low about South Africa’s progress against key NSP indicators.
-
Episode 9: Rensburg on healthcare reform in South Africa
Jul 25, 2019 • 27:36
Host Nomatter Ndebele chats to RHAP director Russell Rensburg about the major reforms underway in the South African healthcare system.
-
Episode 10: Siphiwe Mhlangana on the Treatment Action Campaign’s treatment literacy work
Jul 25, 2019 • 21:15
Host Nomatter Ndebele chats to Siphiwe Mhlangana of the TAC about his treatment literacy work and why treatment literacy still matters.